Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

998484

	registered interest
	date	30/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Abscesses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the cost to the NHS in England of leg ulcers in each of the last 10 years.
	tabling member printed	Lord Wills
	uin	HL11143
	answer	answer is ministerial correction date of answer 13/11/2018 answer text <p>No such assessment has been made as the relevant data is not centrally held by the Department.</p> answering member printed Lord O'Shaughnessy question first answered 13/11/2018 14:23:50 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	260 label Biography information for Lord Wills

998485

	registered interest
	date	30/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Abscesses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the benefits to the NHS in England of early endovenous ablation of leg ulcers.
	tabling member printed	Lord Wills
	uin	HL11144
	answer	answer is ministerial correction date of answer 13/11/2018 answer text <p>The results of the Early Venous Reflux Ablation (EVRA) study (2018) and the Effect of Surgery and Compression on Healing and Recurrence (ESCHAR) trial (2004) indicate that early superficial endovenous ablation improves healing of venous leg ulceration, reduces the risk of ulcer recurrence and is cost-effective.</p><p>Therefore, the results of the EVRA study and the ESCHAR trial will be incorporated into the National Wound Care Strategy Programme recommendations for care, as this will bring benefits to both patients and the National Health Service.</p> answering member printed Lord O'Shaughnessy question first answered 13/11/2018 14:23:41 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	260 label Biography information for Lord Wills

998488

	registered interest
	date	30/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Abscesses
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the efficacy of patient leg ulcer care pathways developed by the Venous Forum of the Royal Society of Medicine.
	tabling member printed	Lord Wills
	uin	HL11147
	answer	answer is ministerial correction date of answer 13/11/2018 answer text <p>NHS England is not aware of any assessments of the efficacy of patient leg ulcer care pathways developed by the Venous Forum of the Royal Society of Medicine.</p><p>There are plans to develop a national patient leg ulcer care pathway, and the Venous Forum has been invited to join the lower limb workstream to contribute to the development of this pathway.</p> answering member printed Lord O'Shaughnessy question first answered 13/11/2018 14:22:15 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	260 label Biography information for Lord Wills

710400

	registered interest
	date	13/03/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mesothelioma
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what estimate they have made of the cost to the NHS of treating mesothelioma in each of the last 10 years.
	tabling member printed	Lord Wills
	uin	HL6004
	answer	answer is ministerial correction date of answer 27/03/2017 answer text <p>The information requested is not held national level.</p> answering member printed Lord O'Shaughnessy question first answered 27/03/2017 16:09:30 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	260 label Biography information for Lord Wills

714751

	registered interest
	date	28/03/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mesothelioma
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by Lord O’Shaughnessy on 27 March, whether any data is collected on the cost of mesothelioma to the NHS; and if so, what.
	tabling member printed	Lord Wills
	uin	HL6371
	answer	answer is ministerial correction date of answer 05/04/2017 answer text <p>Data on the cost of mesothelioma to the National Health Service is not collected centrally.</p> answering member printed Lord O'Shaughnessy question first answered 05/04/2017 14:18:08 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	260 label Biography information for Lord Wills

718246

	registered interest
	date	06/04/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mesothelioma
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by Lord O’Shaughnessy on 5 April (HL6371), whether anyone collects any data on the cost of mesothelioma to the NHS; and if so, who.
	tabling member printed	Lord Wills
	uin	HL6745
	answer	answer is ministerial correction date of answer 24/04/2017 answer text <p>While information is not held centrally, individual trusts may capture data relating to the cost of treating mesothelioma patients. However, this information could only be collected at disproportionate cost.</p> answering member printed Lord O'Shaughnessy question first answered 24/04/2017 13:25:13 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	260 label Biography information for Lord Wills

718247

	registered interest
	date	06/04/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mesothelioma
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by Lord O’Shaughnessy on 5 April (HL6371), whether they have made any estimate of the cost of mesothelioma to the NHS; and if so, what.
	tabling member printed	Lord Wills
	uin	HL6746
	answer	answer is ministerial correction date of answer 24/04/2017 answer text <p>Neither the Department or its arm’s length bodies have made any formal assessment or estimate about the cost of mesothelioma to the National Health Service.</p> answering member printed Lord O'Shaughnessy question first answered 24/04/2017 13:26:04 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	260 label Biography information for Lord Wills

998486

	registered interest
	date	30/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Varicose Veins
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the benefits to people aged over 65 of endovenous ablation treatment of varicose veins.
	tabling member printed	Lord Wills
	uin	HL11145
	answer	answer is ministerial correction date of answer 13/11/2018 answer text <p>Varicose veins can cause complications because they stop blood flowing properly, including venous leg ulcers as a result of chronic venous insufficiency.</p><p>The results of the Early Venous Reflux Ablation (EVRA) study (2018) and the Effect of Surgery and Compression on Healing and Recurrence (ESCHAR) trial (2004) indicate that early superficial endovenous ablation improves healing of venous leg ulceration, reduces the risk of ulcer recurrence and is cost-effective.</p><p>Therefore, the results of the EVRA study and the ESCHAR trial will be incorporated into the National Wound Care Strategy Programme recommendations for care, as this will bring benefits to both patients and the National Health Service.</p><p>The EVRA study and the ESCHAR trial included patients over the age of 65 so the results are applicable to older people. However, no sub-analysis is presented for people over the age of 65 so it is not possible to identify if there are any benefits or risks beyond the overall results for people over 65.</p> answering member printed Lord O'Shaughnessy question first answered 13/11/2018 13:40:14 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	260 label Biography information for Lord Wills